(Q47272020)

English

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors

scientific article published in January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

7

0 references

author name string

Shi-Ming Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Chun-Jung Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Chao-Wei Hsu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Dar-In Tai

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

I-Shyan Sheen

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Deng-Yn Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

100

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

376-382

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Radiofrequency ablation of the liver: current status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Cytologic changes in hepatocellular carcinoma after percutaneous acetic acid injection. Correlation with helical computed tomography findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Hepatocellular carcinoma: an Asian perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47272020&oldid=2229251050"